Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership

Thursday, June 4, 2026Annabel Kartal AllenView original

Eli Lilly’s deal with Ascidian is one of several that the pharma giant has cut within the realm of genetic medicines.

Read the full article on the original site.